Leading mental health care with our comprehensive Dulogen range of duloxetine formulations. From depression and anxiety management to neuropathic pain treatment, our SNRI therapies provide healthcare professionals with proven solutions for optimal patient mental health outcomes.
Our comprehensive Dulogen portfolio offers healthcare professionals multiple strength options of duloxetine to address various mental health conditions and pain disorders with precision and efficacy.
Entry-level SNRI therapy for initial depression and anxiety management. Ideal for patients requiring low-dose initiation with excellent tolerability profile for mood disorder treatment.
Standard-strength SNRI therapy for comprehensive depression and anxiety management. Enhanced efficacy for patients requiring more robust neurotransmitter modulation and pain relief.
High-strength SNRI therapy for treatment-resistant depression and complex pain syndromes. Maximum therapeutic benefit for patients requiring aggressive neurotransmitter modulation and comprehensive symptom control.
Our Dulogen range provides comprehensive therapeutic solutions for a wide spectrum of psychiatric and pain conditions, backed by extensive clinical evidence and proven patient outcomes.
Dulogen effectively modulates serotonin and norepinephrine reuptake to improve mood, energy levels, and overall well-being. Our duloxetine formulations provide significant antidepressant effects with excellent patient tolerability for major depressive disorder and related mood conditions.
Our SNRI therapy provides anxiolytic benefits through dual neurotransmitter modulation, effectively reducing excessive worry, nervousness, and anxiety symptoms. Dulogen offers comprehensive management for generalized anxiety disorder and stress-related conditions.
Dulogen addresses neuropathic pain through central pain pathway modulation, providing significant relief for diabetic peripheral neuropathy and chronic pain conditions. Our formulations offer dual benefits for patients with comorbid depression and pain syndromes.
Our specialized duloxetine therapy addresses the complex nature of fibromyalgia through central sensitization modulation. Dulogen provides comprehensive relief from widespread pain, fatigue, sleep disturbances, and associated mood symptoms in chronic pain patients.
Hitzelberger Life Sciences combines cutting-edge psychiatric research with rigorous pharmaceutical manufacturing to deliver excellence in every Dulogen product.
Our state-of-the-art facilities ensure consistent bioequivalence, optimal stability, and superior therapeutic outcomes. Every Dulogen product undergoes stringent mental health-focused testing and adheres to international pharmaceutical standards, providing healthcare professionals with reliable and effective psychiatric treatment solutions.
Specialized expertise in mental health therapeutic development
Robust psychiatric outcomes data and safety profiles
WHO-GMP compliant production with psychiatric standards
Comprehensive psychiatric medical information services
At Hitzelberger Life Sciences, we are dedicated to advancing psychiatric therapeutics through innovative SNRI formulations and unwavering commitment to mental health outcomes. Our Dulogen range represents years of psychiatric expertise, combining proven duloxetine with advanced pharmaceutical technology to optimize patient mental well-being. We partner with psychiatrists and mental health professionals to ensure every patient receives the most appropriate and effective treatment for their mental health and pain management needs.